{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:51:19Z","timestamp":1794088279760,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.eururo.2010.09.007","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T04:50:03Z","timestamp":1284785403000},"page":"919-926","source":"Crossref","is-referenced-by-count":117,"title":["Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome"],"prefix":"10.1016","volume":"58","author":[{"given":"Hann-Chorng","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hou","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Dong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2010.09.007_bib0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2010.09.007_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2010.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin in patients with non-neurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2010.09.007_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: Urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2010.09.007_bib0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","article-title":"A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity","volume":"96","author":"Rajkumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2010.09.007_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-a toxin injections in the detrusor muscle for idiopathic overactive bladder","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.urology.2006.05.054","article-title":"Will suburothelial injection of a small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?","volume":"68","author":"Kuo","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2010.09.007_bib0045","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0050","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0060","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin A for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1464-410X.2007.07186.x","article-title":"Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity","volume":"100","author":"Jeffery","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2010.09.007_bib0070","unstructured":"Dmochowski R, Chapple C, Nitti V, et al. Botulinum toxin type A (onabotulinumtoxinA) demonstrates dose-dependent efficacy and safety in idiopathic overactive bladder: a double-blind, placebo-controlled, randomized trial. Abstract presented at: American Urological Association Annual Meeting; April 25\u201330, 2009; Chicago, IL, USA."},{"key":"10.1016\/j.eururo.2010.09.007_bib0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eururo.2009.04.020","article-title":"Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks","volume":"57","author":"Khan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0080","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.juro.2008.08.030","article-title":"Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population","volume":"180","author":"White","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2010.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.eururo.2010.09.007_bib0100","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","article-title":"Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity","volume":"54","author":"Kalsi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","article-title":"Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units","volume":"28","author":"Cohen","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2010.09.007_bib0115","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.juro.2010.02.009","article-title":"Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature","volume":"183","author":"Anger","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.juro.2008.11.110","article-title":"What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection","volume":"181","author":"Khan","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0125","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","article-title":"Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder","volume":"181","author":"Flynn","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1464-410X.2008.08076.x","article-title":"Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?","volume":"103","author":"Sahai","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2010.09.007_bib0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.09.007_bib0145","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.urology.2008.04.026","article-title":"Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection","volume":"72","author":"Kuo","year":"2008","journal-title":"Urology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283810008626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283810008626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T20:20:33Z","timestamp":1544214033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283810008626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0302283810008626"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2010.09.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5826956.8169054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.5826956.5810058","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}